Brown, Lisle/Cummings’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
Brown, Lisle/Cummings's G Position: Q2 2026 in Review
Brown, Lisle/Cummings reduced its Genpact (G) stake by 29% in Q2 2026, selling an estimated $2.99K and leaving 221 shares worth $6.08K. The position accounts for ﹤0.01% of the portfolio, ranked #678.
Brown, Lisle/Cummings first reported a position in G in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.6K in Q1 2026. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.
- Brown, Lisle/Cummings held 221 shares of Genpact worth $6.08K as of Q2 2026.
- Brown, Lisle/Cummings sold 91 Genpact shares in Q2 2026, an estimated $2.99K.
- Genpact made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #678 holding.
- Brown, Lisle/Cummings first reported a position in Genpact in Q1 2026 and has held it in 2 quarters since.
- Brown, Lisle/Cummings's Genpact position peaked at $11.6K in Q1 2026.
- 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.